Apnea of Prematurity
Definition
- cessation of breathing for more than 20 seconds or shorted if accompanied by
- bradycardia
- hypoxemia
- cyanosis
- oxygen saturation
- hypotonia
- pallor
Intermittent Hypoxia - short and repetitive episodes of hypoxemia and desaturation which not accompanied by bradycardia and apnea
Classification
- central apnea (40%)- inspiratory efforts are absent
- obstructive apnea (10%) - inspiratory efforts present, but airway obstruction is cause of hypoxia
- Mixed apnea (50%) - airway obstruction precedes central apnea most common cause of apnea
Epidemiology
- premature infants (almost all babies <28 weeks)
- present within week of birth
- cease by 34 to 37 weeks of PMA
- apnea in late preterm/term born infants - always associated with serious identifiable causes such as sepsis, hypoglycemia, birth asphyxia, intracranial hemorrhage, seizure, depression
Pathogenesis
- physiological immaturity of the control of breathing mechanisms
- these can be precipitated by
- chemoreceptor response (decreased sensitivity to high carbon dioxide and low oxygen)
- reflexes of posterior pharynx, stimulated by suction, choking on secretions
- airway obstruction due to neck flexion, nasal obstruction
- REM sleep (which predominate in preterm)
- antiseizure medication induced breathing inhibition
Management of AOP
Who to monitor
- all preterm babies less than 34 weeks
- in case of ELBW babies (<28 weeks), apnea can persist beyond 40 weeks PMA
Emergency management of Apnea
- check hypoxia, bradycardia, and loss of tone
- stimulate the baby
- if no response to stimulation, start PPV (preferably with T-piece), with mixed air and oxygen
- CPAP and HFNC can be considered
- intubation and ventilation
Management of Apnea after stabilization
- identify the cause
Cause | Signs | Evaluation |
---|---|---|
Airway | secretion, KMC, feed regurgitation | correct feeding position |
Metabolic disorders | Jitteriness, lethargy, fedding difficulty, CNS depression | Glucose, calcium, blood gas, electrolytes |
Infection | Not looking well, lethargy, temperature, shock, sugar, | Blood culture, urine culture, CBC, CRP, CSF examination |
NEC | feed intolerance, GI aspirate | Abdominal X ray |
Anemia | blood loss | Hematocrit |
Impaired oxygenation | hypoxia, tachypnea, RD | BG analysis, CXR |
Temperature instability | lethargy | monitor temperature |
Drugs | antenatal MgSO4, Antinatal AED | check drug level |
IVH | seizure, pallor, bulging fontenalle | USG cranium |
Inborn errors of metabolism | Jitteriness, poor feeding, lethargy, irritablity, CNS depression | lactate, ammonia, metabolic screening |
PDA | tachycardia, bounding pulse, murmur, hyperkinetic precordium | CXR, Echo |
Algorithm
Prevention of recurrence
Caffeine
- Drug of choice
- MOA : antagonism of adenosine receptors
- half life 5-7 days
- uses of caffeine in AOP
- stimulation of respiratory center of medulla
- enhances diaphragmatic contractility
- increased sensitivity to carbon dioxide
- mild diuretic effect
- increases minute ventilation
- decreases periodic breathing
- uses of caffeine in BPD
- reduce BPD through immunomodulatory effect
- antioxidant
- antifibrotic
- antiapoptotic
- regulation of angiogenesis
- diuretic effects
- adverse effects of caffeine
- tachycardia
- hypoglycemia
- increased metabolism
- sleep disturbances
- indications
- preemies with risk of apnea
- prior to extubation of ventilated preterm <32 weeks (<34 weeks - WHO)
- limited prophylactic use
- earlier caffeine use in 1st 3 days of life is beneficial
- loading at 20 mg/kg over 30 mins followed by 5mg/kg maintenance
- higher doses (30 to 80 mg/kg) can be tried if poor response to conventional doses, increased risk of IVH
- stop caffeine when child reaches 32 weeks (or 34 weeks if child born very preterm)
Aminophylline
- narrow therapeutic range
- increased side effects compared to Caffeine
- loading with 5-6 mg/kg and maintain with 1.5-3 mg/kg q8h - q12h
Oxygen
- free flow oxygen reduces apnea
- can be given as low FiO2
Avoid triggers
- suction to be done carefully
- avoid neck flexion
- avoid hypo/hyperthermia
When to discharge
- apnea free period of 5 to 7 days
- monitored closely at least till 44 weeks PMA, especially with associated BPD
- DTwP is associated with more apnea than DTaP